Leung and colleagues showed that another member of the microdissected CAF-specific gene signature, microfibrillar-associated protein 5 (MFAP5), is a prognostic marker of poor survival rates in patients with ovarian cancer. This evidence concerns the gene MFAP5 and ovarian carcinoma.